| Source of record | UK Trials |
| ISRCTN | ISRCTN06813178 |
| Date ISRCTN assigned | 11/02/2003 |
| Local reference number(s) | G106/991 |
| Public title | Randomised controlled trial and economic evaluation of domiciliary medication review by pharmacists in Norfolk & Suffolk |
| Scientific title |
|
| Acronym | The HOMER trial |
| Disease/condition/study domain | Not Applicable |
| Study hypothesis | To determine whether domiciliary medication review leads to reductions in emergency hospital admissions and an improvement in quality of life compared to standard care among elderly subjects (80 years old and over). |
| Design/methodology | Randomised controlled trial |
| Research ethics review | Not provided at time of registration.
|
| Countries of trial | United Kingdom |
| Participants - inclusion criteria | 1. Discharged after an emergency hospital admission 2. 80 years and over 3. Prescribed two or more daily medications 4. Living in own home or warden controlled accommodation 5. Norfolk or Suffolk resident |
| Participants - exclusion criteria | Living in a residential or nursing home. |
| Patient information material |
|
| Anticipated start date | 01/01/2001 |
| Anticipated end date | 31/12/2004 |
| Status of trial | Completed |
| Target number of participants | 850 |
| Interventions | Two groups: Control group received standard care (whatever that entails). Intervention group are referred to a review pharmacist. The review pharmacist will complete a standard medication review form and will then arrange a home visit at a time when they can meet the patient and any carers helping them with their drugs. The home visit will include a brief assessment of their ability to self-medicate and an assessment of drug compliance. The review pharmacist will, where appropriate: a. Educate the patient/carer b. Remove out-of-date drugs (with the patient's consent) c. Feedback to the GP possible drug reactions/interactions d. Feedback to the local pharmacist the need for a compliance aid. One follow-up visit will occur at 6-8 weeks post-recruitment to allow reinforcement of the original advice. |
| Primary outcome measure(s) | Total number of emergency hospital admissions by 6-months |
| Secondary outcome measure(s) | 1. Total number of emergency hospital admissions by 3 months 2. Hospital/nursing/residential home admissions for respite care by 3 & 6 months 3. Admissions to nursing/residential care for long-term care by 3 & 6 months 4. Deaths by 3 & 6 months 5. Self-assessed quality of life at 3 & 6 months (using EQ-5D) 6. Average medication costs at 6 months |
| Publications | Results: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids= 15665005 |
| Sources of funding | NHS Eastern Region R&D (reference number: HSR/1199/2) (UK) Medical Research Council (reference number: G106/991) (UK) Norfolk Health Authority (no reference number allocated) (UK) Norfolk Social Services (no reference number allocated) (UK) Suffolk Social Services (no reference number allocated) (UK) Pharmacy Practice Unit, UEA (no reference number allocated) (UK) |
| Sponsor name | Medical Research Council (UK) |
| Sponsor details | 20 Park Crescent London United Kingdom W1B 1AL |
| Sponsor telephone | +44 (0)20 7636 5422 |
| Sponsor fax | +44 (0)20 7436 6179 |
| Sponsor email | clinical.trial@headoffice.mrc.ac.uk |
| Sponsor website | http://www.mrc.ac.uk |
| Contact name | Dr Richard Holland |
| Contact details | School of Medicine Health Policy & Practice University of East Anglia Norfolk Norwich United Kingdom NR4 7TJ |
| Contact telephone | +44 (0)1603 593574 |
| Contact fax | +44 (0)1603 593752 |
| Contact email | r.holland@uea.ac.uk |
| More information | For more up-to-date information please go to the ISRCTN link below. |
| Link to record in ISRCTN Register | ISRCTN06813178 |
| Date last extracted from ISRCTN register | 17/04/2008 |